280 related articles for article (PubMed ID: 32921328)
1. Probiotics and Coronavirus disease 2019: think about the link.
Angurana SK; Bansal A
Br J Nutr; 2021 Nov; 126(10):1564-1570. PubMed ID: 32921328
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
4. Role of Probiotics in the Management of COVID-19: A Computational Perspective.
Nguyen QV; Chong LC; Hor YY; Lew LC; Rather IA; Choi SB
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057455
[TBL] [Abstract][Full Text] [Related]
5. The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic.
Lee E; Hong SJ
Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):245-251. PubMed ID: 33769313
[TBL] [Abstract][Full Text] [Related]
6. Probiotics and Covid-19.
Bottari B; Castellone V; Neviani E
Int J Food Sci Nutr; 2021 May; 72(3):293-299. PubMed ID: 32787470
[TBL] [Abstract][Full Text] [Related]
7. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
8. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.
Ailioaie LM; Litscher G
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066560
[TBL] [Abstract][Full Text] [Related]
9. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
Barengolts E; Smith ED
Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between immune system and microbiota in COVID-19.
Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Chattopadhyay I; Shankar EM
Front Cell Infect Microbiol; 2021; 11():590874. PubMed ID: 33791231
[TBL] [Abstract][Full Text] [Related]
12. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.
Spagnolello O; Pinacchio C; Santinelli L; Vassalini P; Innocenti GP; De Girolamo G; Fabris S; Giovanetti M; Angeletti S; Russo A; Mastroianni CM; Ciccozzi M; Ceccarelli G; d'Ettorre G
Chemotherapy; 2021; 66(1-2):24-32. PubMed ID: 33756475
[TBL] [Abstract][Full Text] [Related]
13. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm.
Zeinali T; Faraji N; Joukar F; Khan Mirzaei M; Kafshdar Jalali H; Shenagari M; Mansour-Ghanaei F
Microb Pathog; 2022 Sep; 170():105704. PubMed ID: 35948266
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
Mirzaei R; Attar A; Papizadeh S; Jeda AS; Hosseini-Fard SR; Jamasbi E; Kazemi S; Amerkani S; Talei GR; Moradi P; Jalalifar S; Yousefimashouf R; Hossain MA; Keyvani H; Karampoor S
Arch Virol; 2021 Jul; 166(7):1819-1840. PubMed ID: 33745067
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
Lau HC; Ng SC; Yu J
Gastroenterology; 2022 Jan; 162(1):9-16. PubMed ID: 34508775
[No Abstract] [Full Text] [Related]
16. Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
Brahma S; Naik A; Lordan R
Clin Nutr ESPEN; 2022 Oct; 51():17-27. PubMed ID: 36184201
[TBL] [Abstract][Full Text] [Related]
17. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
Wang M; Zhang Y; Li C; Chang W; Zhang L
Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
[TBL] [Abstract][Full Text] [Related]
19. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19.
Gharajeh NH; Pourjafar H; Derakhshanian H; Mohammadi H; Barzegari A; Eslami S
Curr Pharm Biotechnol; 2022; 23(15):1837-1850. PubMed ID: 35379123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
